Liver cancer patients: do targeted drugs before transplant boost survival?
Knowledge-focused
Completed
This study looked back at data from 484 liver cancer patients who had a liver transplant to see if taking targeted therapy (tyrosine kinase inhibitors) before the transplant helped them live longer or kept the cancer from coming back. The researchers checked survival rates, cance…
Sponsor: Hu Liangshuo • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC